Jaya Lakkakula

Dr. Jaya Lakkakula

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
JLJaya Lakkakula
Jaya Lakkakula
PGPratik Gujarathi
Pratik Gujarathi
PPPrachi Pansare
Prachi Pansare
STSwastika Tripathi
Swastika Tripathi

1 May 2014 in Nanomedicine
Verified
Journal Article
Closed access
JLJaya Lakkakula
Jaya Lakkakula
RKRui Krause
Rui Krause
Cyclodextrins (CDs) have brought a revolution in the pharmaceutical field over the last decade. Natural and modified CDs (α-CD and β-CD) have been studied and some have gained US FDA approval or achieved 'Generally Regarded as Safe' (GRAS) status. Another characteristic of CDs is the ease with which they can be induced to form supramolecular structures for its use in drug delivery. CDs, grafted or crosslinked with polymers, are now being developed into 'smart' systems for efficient targeted drug delivery, especially for hydrophobic drugs. Amphiphilic CDs have the ability to form nanospheres or nanocapsules via a simple nanoprecipitation technique. This review deals with different types of CDs, and their efficacy, physicochemical properties and transformation into nanoparticles with interesting in vitro and in vivo applications.

1 January 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JLJaya Lakkakula
Jaya Lakkakula
TMThabo Matshaya
Thabo Matshaya
RKRui Krause
Rui Krause

1 February 2019 in Materials Letters
Verified
Journal Article
Closed access
DDDeepika Divakaran
Deepika Divakaran
JLJaya Lakkakula
Jaya Lakkakula
MTMukeshchand Thakur
Mukeshchand Thakur
MKMukesh Kumar Kumawat
Mukesh Kumar Kumawat
RSRohit Srivastava
Rohit Srivastava

28 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
PSPooja Kaduba Salve
Pooja Kaduba Salve
AVAruna Vinchurkar
Aruna Vinchurkar
RRRajesh Raut
Rajesh Raut
RCRamesh Chondekar
Ramesh Chondekar
JLJaya Lakkakula
Jaya Lakkakula
MAMohd Fahami Nur Azlina
Mohd Fahami Nur Azlina
In the current decade, nanoparticles are synthesized using solvents that are environmentally friendly. A number of nanoparticles have been synthesized at room temperature using water as a solvent, such as gold (Au) and silver (Ag) nanoparticles. As part of nanotechnology, nanoparticles are synthesized through biological processes. Biological methods are the preferred method for the synthesis of inorganic nanoparticles (AgNPs) as a result of their simple and non-hazardous nature. Nanoparticles of silver are used in a variety of applications, including catalysts, spectrally selective coatings for solar absorption, optical objectives, pharmaceutical constituents, and chemical and biological sensing. Antimicrobial agents are among the top uses of silver nanoparticles. In the current study, silver nanoparticles were biologically manufactured through Madhuca longifolia, and their antibacterial activity against pathogenic microorganisms, anticancer, anti-inflammatory, and antioxidant activities were assessed. UV-Vis spectroscopy, XRD (X-ray diffraction), transmission electron microscopy, Zeta Potential, and FTIR were used to characterize silver nanoparticles. The current work describes a cheap and environmentally friendly method to synthesize silver nanoparticles from silver nitrate solution by using plant crude extract as a reducing agent.

8 September 2022 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
AKAnandakrishnan Karthic
Anandakrishnan Karthic
ARArpita Roy
Arpita Roy
JLJaya Lakkakula
Jaya Lakkakula
SASaad Alghamdi
Saad Alghamdi
ASAfnan Shakoori
Afnan Shakoori
HCHenrique Douglas Melo Coutinho
Henrique Douglas Melo Coutinho
Cancer is still one of the world’s deadliest health concerns. As per latest statistics, lung, breast, liver, prostate, and cervical cancers are reported topmost worldwide. Although chemotherapy is most widely used methodology to treat cancer, poor pharmacokinetic parameters of anticancer drugs render them less effective. Novel nano-drug delivery systems have the caliber to improve the solubility and biocompatibility of various such chemical compounds. In this regard, cyclodextrins (CD), a group of natural nano-oligosaccharide possessing unique physicochemical characteristics has been highly exploited for drug delivery and other pharmaceutical purposes. Their cup-like structure and amphiphilic nature allows better accumulation of drugs, improved solubility, and stability, whereas CDs supramolecular chemical compatibility renders it to be highly receptive to various kinds of functionalization. Therefore combining physical, chemical, and bio-engineering approaches at nanoscale to specifically target the tumor cells can help in maximizing the tumor damage without harming non-malignant cells. Numerous combinations of CD nanocomposites were developed over the years, which employed photodynamic, photothermal therapy, chemotherapy, and hyperthermia methods, particularly targeting cancer cells. In this review, we discuss the vivid roles of cyclodextrin nanocomposites developed for the treatment and theranostics of most important cancers to highlight its clinical significance and potential as a medical tool.